XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3Close
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:              
Net earnings $ 1,569 $ 1,188 $ 1,781 $ 1,047 $ 4,391 $ 4,222  
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities              
Change in receivables and advance premiums         42 10  
Capitalization of deferred policy acquisition costs         (804) (770)  
Amortization of deferred policy acquisition costs 201   194   608 598 $ 792
Increase in policy liabilities         (99) 717  
Change in income tax liabilities         (289) (491)  
Net investment (gains) losses (423)   (199)   (1,101) (885)  
Other, net         (391) (555)  
Net cash provided (used) by operating activities         2,357 2,846   Close
Proceeds from investments sold or matured:              
Available-for-sale fixed maturity securities         2,112 2,997  
Equity securities         353 518  
Held-to-maturity fixed maturity securities         2 2  
Commercial mortgage and other loans         1,276 1,849  
Costs of investments acquired:              
Available-for-sale fixed maturity securities         (2,359) (2,961)  
Equity securities         (299) (414)  
Commercial mortgage and other loans         (744) (3,552)  
Other investments, net         (902) (54)  
Settlement of derivatives, net         56 (159)  
Cash received (pledged or returned) as collateral, net         2,894 769  
Other, net         (160) 158  
Net cash provided (used) by investing activities         2,229 (847)   Close
Cash flows from financing activities:              
Purchases of treasury stock         (2,100) (1,801)  
Proceeds from borrowings         0 1,277  
Principal payments under debt obligations         0 (966)  
Dividends paid to shareholders         (730) (740)  
Change in investment-type contracts, net         (114) (61)  
Treasury stock reissued         9 15  
Other, net         (1) 20  
Net cash provided (used) by financing activities         (2,936) (2,256)   Close
Effect of exchange rate changes on cash and cash equivalents         (91) (84)   Close
Net change in cash and cash equivalents         1,559 (341)   Close
Cash and cash equivalents, beginning of period   $ 3,943   $ 5,051 3,943 5,051 5,051
Cash and cash equivalents, end of period $ 5,502   $ 4,710   5,502 4,710 $ 3,943
Supplemental disclosures of cash flow information:              
Income taxes paid         870 600  
Interest paid         132 153  
Noncash interest         16 17  
Noncash real estate acquired in satisfaction of debt         90 0  
Noncash financing activities:              
Lease obligations         50 72  
Associate stock bonus              
Treasury stock issued for:              
Treasury stock issued         13 11  
Shareholder dividend reinvestment              
Treasury stock issued for:              
Treasury stock issued         28 28  
Share-based compensation grants              
Treasury stock issued for:              
Treasury stock issued         $ 5 $ 6